Adults with epilepsy and hearing loss who use hearing aids [...]
Cereno Scientific has reported encouraging 12-month safety and clinical observations [...]
China’s approval of a first dual BAFF/APRIL therapy in IgA [...]
Racura Oncology has treated the first patient in its Harness-1 [...]
EMBARC has announced its intention to collaborate with Insmed on [...]
Orphan Therapeutics Accelerator has expanded its development network for ultra-rare [...]
Phase 2 trial begins for fetal growth restriction therapy with no approved drug treatments available
The first patients have been dosed in a Phase 2 [...]
CORXEL Pharmaceuticals reported positive Phase 2 results for oral GLP-1 [...]
NICE has recommended cemiplimab for eligible adults with recurrent or [...]
Meteor Biotech has joined a South Korean government-backed consortium aimed [...]